4th Quarter - Report
GENENTECH, INC for GENENTECH INC
Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1548 - "Pathway for Biosimilars Act" H.R. 3962 - "Affordable health Care for America Act - Follow-on biologics provisions H.R. 3590 - "Patient Protection and Affordable Care Act"
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON New | — |
| DARIN GARDNER New | — |
| EVAN MORRIS New | — |
Medicare/Medicaid MMM
H.R. 3962 - "Affordable health Care for American Act, opposition to Medicare rebates and coding and payment for follow-on biologics H.R. 3590 - "Patient Protection and Affordable Care Act", opposition to Medicare rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| STEPHANIE A DYSON New | — |
| DARIN GARDNER New | — |
| EVAN MORRIS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.